PLAC1 antibody (C-Term)
Quick Overview for PLAC1 antibody (C-Term) (ABIN783753)
Target
See all PLAC1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- This antibody detects PLAC1 at C-term.
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogen
- 15 amino acid peptide near the carboxy terminus of human PLAC1
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS containing 0.02 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2 - 8 °C for up to three months or (in aliquots) at -20 °C for longer.
-
-
- PLAC1 (Placenta-Specific 1 (PLAC1))
-
Alternative Name
- PLAC1
-
Background
- PLAC1 was initially identified as a protein expressed specifically in the placenta and other cells derived from the trophoblast lineage during embryonic development, but has also been found to be expressed ectopically in a wide range of human malignancies, particularly breast cancers. PLAC1 is a membrane-associated protein that is thought to serve a receptor-like function modulating cell-cell or ligand receptor interactions unique to the maternal-placental interface. Decreased expression of PLAC1 is associated with decreased expression of cyclin D1 and reduced expression of AKT kinase, which, combined with the fact that PLAC1 is expressed on the surface of cancer cells, suggests that PLAC1 may be an effective candidate for immunotherapeutic treatments of cancer.Synonyms: Placenta-specific protein 1
-
Gene ID
- 10761
-
NCBI Accession
- NP_068568
-
UniProt
- Q9HBJ0
Target
-